Japan’s Probiotics market is projected to grow at a CAGR of 7.57% to reach US$12.123 billion by 2027, from US$7.274 billion in 2020.
Probiotics are living microorganisms that have health benefits when they are either consumed or applied to the body. Probiotics contain good bacteria that help in digesting food, destroy disease-causing cells, and produce vitamins. They also help in maintaining a healthy balance in the body. Naturally, probiotics are found in yogurt. The food and drug administration (FDA) regulates probiotics like foods, and not like medications. Probiotic intake is considered healthy and a smart choice among them due to its clinically proven health benefits.
Growing preventive healthcare in Japan
Japan is one of the most developed economies in the world. The country has developed despite having a lack of natural resources. Japan has always given importance to human resources; therefore, it has heavily invested in healthcare and education. The government has undertaken several measures toward preventive healthcare, such as the expansion of insurance coverage. In addition, the Japanese are well aware of the importance of incorporating probiotic bacteria and prebiotic ingredients in their daily diets. Furthermore, according to World Bank Data, Japan’s age dependency ratio reached 49% in 2021, which is an indication of the increasing aging population. This is fueling the demand for probiotics as probiotic supplements may be effective in counteracting age-related shifts as they help to restore the natural diversity of human gut bacteria, strengthen the immune system, and positively impact cognition and mood which impacts health outcomes and promote healthy aging.
Market Developments
Therefore, the market players are making mindful investments and launches to expand the product offering for the market. For instance,
COVID-19 Insights
The COVID-19 pandemic caused millions of deaths worldwide. It severely hampered the immunity of individuals. However, the pandemic had a positive impact on the Japanese probiotics market. As probiotics are known to restore a stable gut microbiota by regulating innate and adaptive immunity within the gut, they were used to combat COVID-19 because of several pieces of evidence that suggested that COVID-19 has an adverse impact on gut microbiota dysbiosis. Thus, probiotics were used for their antiviral properties as an adjunctive treatment to combat COVID-19. Several clinical trials were also undertaken, which proved the efficacy of probiotics and their metabolites in treating patients with the virus.
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Market Size Value in 2020 | US$7.274 billion |
| Market Size Value in 2027 | US$12.123 billion |
| Growth Rate | CAGR of 7.57% from 2020 to 2027 |
| Base Year | 2020 |
| Forecast Period | 2022–2027 |
| Forecast Unit (Value) | USD Billion |
| Segments Covered | Type, Form, Application, And End-User |
| Companies Covered | Yakult, Asahi Group Holdings, Ltd., Nissin Food Products Co., Ltd., Kirin Holdings Company, Limited., Morishita Jintan Co., Ltd |
| Customization Scope | Free report customization with purchase |
Segmentation: